Hepatic Impairment Completed Phase 4 Trials for Naloxone (DB01183)

Also known as: Liver impairment / Diseases of liver (K70-K77) / Hepatic pathology / Fector hepaticus / [X]Diseases of the liver / Hepatopathy / Hepatic disease NOS / Hepatic disorder (NOS) / Disorder hepatic / Hepatic disorder NOS / Disease hepatocellular / Disorder liver / Hepatic disease / Hepatic disease (NOS) / Liver disorder / Liver Diseases / Unspecified disorder of liver

IndicationStatusPhase
DBCOND0031585 (Hepatic Impairment)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01846455Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired SubjectsTreatment